Skip to content

Message from ACell President and CEO regarding COVID-19 View details


Mar. 23, 2016

ACell®, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices

Columbia, MD – (March 23, 2016) – ACell, Inc. today announced that it has received additional FDA clearance for its MicroMatrix® device, which describes the concurrent use of MicroMatrix® in...

Read More
Jan. 20, 2016

ACell®, Inc. Signs Purchasing Agreement with HealthTrust

Columbia, Maryland – (January 20, 2016) – ACell, Inc., a regenerative medicine company focused on the development, manufacturing, and commercialization of tissue repair products, today announced that it has signed...

Read More
Jan. 11, 2016

ACell®, Inc. Names Patrick McBrayer Chief Executive Officer

Columbia, MD – (January 11, 2016) – ACell, Inc. today announced that it has named Patrick (Pat) McBrayer President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain...

Read More
White Acell Logo
ACell Inc.
6640 Eli Whitney Drive
Columbia, MD 21046
High Contrast Mode